Patient-Oriented Research of Liver Disease
Patient-Oriented Research of Liver Disease
批准号:
8011151
负责人:
NAGA P CHALASANI
金额:
$3.49万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-01-15 至 2010-12-31
关键词:
AddressAdultAgeAlcohol consumptionAlkane 1-monooxygenaseAnimal ModelAnthropometryAreaAwardCYP2E1 geneCYP4A11 geneChildChildhoodChlorzoxazoneChronicCirrhosisClinicalClinical InvestigatorClinical PharmacologyClinical ResearchCytochrome P450Dicarboxylic AcidsDietDietary intakeDiseaseDisulfiramEnrollmentEnzymesExtramural ActivitiesFacultyFatty AcidsFatty LiverFibrosisFundingGenderGoalsGrantHepaticHepatologyHepatotoxicityHistologicHumanIndianaIndividualInflammationInjuryInpatientsInsulin ResistanceKetonesLearningLipid PeroxidationLipidsLiverLiver diseasesMeasuresMentorsMentorshipMessenger RNAMetforminMethionineMinorMusNational Institute of Diabetes and Digestive and Kidney DiseasesNonesterified Fatty AcidsObesityOxidative StressPathogenesisPathway interactionsPatientsPeer ReviewPharmaceutical PreparationsPlasmaPlayPopulationProcessProductionProductivityProteinsProtocols documentationPublicationsRelative (related person)ResearchResearch PersonnelResourcesRoleSerumShunt DeviceSourceTestingTimeUnited StatesUnited States National Institutes of HealthUniversitiesbasecytokinein vivoinhibitor/antagonistinsulin sensitizing drugsinterestinvestigator trainingnonalcoholic steatohepatitisoxidationpatient oriented researchprogramsresearch studystemtranslational studyurinary
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by candidate):
This proposal is submitted to seek funding to support additional protected time for Dr. Naga Chalasani so that he can dedicate his efforts to continue his own patient-oriented research and to provide mentorship for the new and junior investigators. Dr. Chalasani has a proven track record in patient-oriented research with more than 50 peer-reviewed publications and strong extramural funding. He has a successful record in mentoring GI/Hepatology (Gl) and Clinical Pharmacology fellows to conduct patient-oriented research in the area of clinical pharmacology aspects of liver disease. Heavy clinical responsibilities are limiting his ability to keep focused on his research and mentorship goals. If funded, this award will protect his time and help him sustain the momentum and productivity he has generated. His research goal is to become a senior investigator in patient-oriented research related to non-alcoholic steatohepatitis (NASH) and the relationship between cytochrome P450 enzymes (CYPs) and liver disease. During the funding period, the candidate will conduct the following patient-oriented research studies: (1) Studies stemming from the NASH Clinical Research Network which is funded by the NIDDK, (2) Studies stemming from the Hepatotoxicity Clinical Research Network which is funded by the NIDDK, (3) Studies stemming from the grant "Effect of Cirrhosis and shunts on drug disposition" which is funded by the NIDDK, and (4) Studies stemming from the grant "Pathogenesis of Non-alcoholic steatohepatitis" which was submitted to NIH for funding. The last set of translational studies will evaluate the role of altered CYPs in the pathogenesis of NASH in adults and children. His mentorship goal is to mentor the interested fellows and junior faculty to conduct patient-oriented research in the area of chronic liver disease as it relates to cytochrome P450 enzymes. The sources for the candidates to be mentored by Dr. Chalasani include adult and pediatric Gl fellows and junior faculty, Clinical Pharmacology fellows and the trainees enrolled in the Indiana University's Clinical Investigator Training Enhancement (CITE) Program. His mentoring plans are (1) to provide methodological and content assistance to the trainees, (2) to provide guidance related to regulatory aid compliance aspects of the patient-oriented research, (3) to provide protocol-specific opportunities for the trainees to get directly involved in patient-oriented research, (4) to provide on-and off-campus learning resources to enhance their ability to conduct patient-oriented research, and (5) to provide assistance with grant submission for intra-and extramural funding and publication of their research findings.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ancillary Studies of NAFLD and NASH in HIV infected Adults
-
批准号:9754980
-
项目类别:
-
资助金额:$170.31万
-
财政年份:2020
-
负责人:NAGA P CHALASANI
-
依托单位:
Ancillary Studies of NAFLD and NASH in HIV infected Adults
-
批准号:10371070
-
项目类别:
-
资助金额:$155.9万
-
财政年份:2020
-
负责人:NAGA P CHALASANI
-
依托单位:
Ancillary Studies of NAFLD and NASH in HIV infected Adults
-
批准号:10555206
-
项目类别:
-
资助金额:$154.26万
-
财政年份:2020
-
负责人:NAGA P CHALASANI
-
依托单位:
Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-IU)
-
批准号:8427105
-
项目类别:
-
资助金额:$94.85万
-
财政年份:2012
-
负责人:NAGA P CHALASANI
-
依托单位:
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 2/9
-
批准号:10440312
-
项目类别:
-
资助金额:$49.35万
-
财政年份:2012
-
负责人:NAGA P CHALASANI
-
依托单位:
Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-IU)
-
批准号:8921359
-
项目类别:
-
资助金额:$6.68万
-
财政年份:2012
-
负责人:NAGA P CHALASANI
-
依托单位:
Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-IU)
-
批准号:8695260
-
项目类别:
-
资助金额:$100.62万
-
财政年份:2012
-
负责人:NAGA P CHALASANI
-
依托单位:
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 2/9
-
批准号:10203744
-
项目类别:
-
资助金额:$52.25万
-
财政年份:2012
-
负责人:NAGA P CHALASANI
-
依托单位:
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 2/9
-
批准号:9589466
-
项目类别:
-
资助金额:$36.88万
-
财政年份:2012
-
负责人:NAGA P CHALASANI
-
依托单位:
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 2/9
-
批准号:9988081
-
项目类别:
-
资助金额:$15.56万
-
财政年份:2012
-
负责人:NAGA P CHALASANI
-
依托单位:
Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-IU)
-
批准号:8545656
-
项目类别:
-
资助金额:$88.0万
-
财政年份:2012
-
负责人:NAGA P CHALASANI
-
依托单位:
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 2/9
-
批准号:9752395
-
项目类别:
-
资助金额:$22.55万
-
财政年份:2012
-
负责人:NAGA P CHALASANI
-
依托单位:
Collaborative Clinical Research on Non Alcoholic Stratohepatitis
-
批准号:8079827
-
项目类别:
-
资助金额:$21.77万
-
财政年份:2010
-
负责人:NAGA P CHALASANI
-
依托单位:
Collaborative Clinical Research on Non Alcoholic Stratohepatitis
-
批准号:8013365
-
项目类别:
-
资助金额:$14.48万
-
财政年份:2010
-
负责人:NAGA P CHALASANI
-
依托单位:
Collaborative Clinical Research on Non Alcoholic Stratohepatitis
-
批准号:8012966
-
项目类别:
-
资助金额:$14.42万
-
财政年份:2010
-
负责人:NAGA P CHALASANI
-
依托单位:
IU Clinical Center: Drug Induced Liver Injury Network
-
批准号:8029381
-
项目类别:
-
资助金额:$10.24万
-
财政年份:2010
-
负责人:NAGA P CHALASANI
-
依托单位:
Nonalcoholic steatohepatitis and Cytochrome P450 Enzymes
-
批准号:7212797
-
项目类别:
-
资助金额:$25.55万
-
财政年份:2007
-
负责人:NAGA P CHALASANI
-
依托单位:
PIOGLIATAZONE VERSUS VITAMIN E VERSUS PLACEBO FOR THE TREATMENT OF NON-DIABETIC
-
批准号:7717520
-
项目类别:
-
资助金额:$0.33万
-
财政年份:2007
-
负责人:NAGA P CHALASANI
-
依托单位:
IDIOSYNCRATIC LIVER INJURY ASSOCIATED WITH DRUGS (ILIAD): A RETROSPECTIVE STUDY
-
批准号:7717524
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2007
-
负责人:NAGA P CHALASANI
-
依托单位:
NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DATABASE
-
批准号:7717523
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2007
-
负责人:NAGA P CHALASANI
-
依托单位:
海外基金